---
figid: PMC6205963__fgene-09-00500-g001
figtitle: Fibroblast of Growth Factor (FGF) signaling activation and regulation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6205963
filename: fgene-09-00500-g001.jpg
figlink: /pmc/articles/PMC6205963/figure/F1/
number: F1
caption: 'Fibroblast of Growth Factor (FGF) signaling activation and regulation. (A)
  Schematic of FGF subfamilies (see ). FGF10 belongs to the FGF7 subfamily and is
  highlighted in blue. (B) Comparison of FGF10 gene/protein in human and mouse. The
  human FGF10 gene has an extra exon; and the protein length in the two species differs
  by one amino acid. FGF10 is secreted via the canonical ER-Golgi secretory pathway,
  as demonstrated by the cleavage of the signal peptide, and have two known glycosylation
  sites (Source: UniProt). (C) Known disease-causing mutations on Fgf10 and Fgfr2
  genes. The rare developmental disorders Aplasia of Lacrimal and major Salivary Glands
  (ALSG), Lacrimo-Auricuo-Dentro-Digital (LADD) syndrome, Aperts’ Syndrome and Bent
  Bone Dysplasia Syndrome (BBDS) result from either the loss of key receptor-binding
  sites on FGF10 or mutations in the receptor kinase (TK) domains or IgII linker regions
  (; , ; , ; ; ; ). Interestingly, cases of ALSG caused by the R193X mutation also
  coincide with Chronic Obstructive Pulmonary Disease (COPD) (). More recently, chromosomal
  translocation and duplication events at the loci of the Fgf10 and Fgfr2 genes have
  been associated with neurological disorders such as developmental delay and autism
  (; ). The role of single nucleotide polymorphisms and de novo point mutations causing
  oncogenic expression of Fgf10 and Fgfr2 are also becoming clearer, particularly
  in pancreatic, gastric, and breast cancers (; ; ; ; ; ; ; ). (D) FGF10-dependent
  activation of FGFR intracellular tyrosine residues (Y; insert), adaptor proteins
  (gray), protein kinases (red), and transcription factors (blue). Insert on the right:
  each square represents a phosphorylated tyrosine residue (Y); the numbers correspond
  to phosphorylated Y residues on FGFR2b identified by proteomics; the color blue
  indicates higher phosphorylation at a given time point upon FGF10 stimulation of
  epithelial cells; modified from . Dashed arrows represent FGF10-specific activation
  or inhibition of signaling. The lightning bolt represents the activation of signaling
  cascades. (E) Left, FGF10 bound to heparan sulfate proteoglycans (HSPGs) in the
  ECM does not activate FGFR and intracellular signaling. Right, FGF10 bound to HSPGs
  and FGFR induces the recruitment of protein adaptors to FGFR and signaling activation
  (represented by lightning bolts). (F) Schematic representation of FGF10 regulation
  in response to hormones (orange), miRNAs (dark green), WNT and SHH proteins. (G)
  FGF10 induces FGFR2b internalization into early endosomes and sorting to recycling
  endosomes and plasma membrane. FGF10 has also been found in the nucleus of certain
  cell types.'
papertitle: Regulation of FGF10 Signaling in Development and Disease.
reftext: Joanne Watson, et al. Front Genet. 2018;9:500.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5080275
figid_alias: PMC6205963__F1
figtype: Figure
redirect_from: /figures/PMC6205963__F1
ndex: 02c0c25a-df31-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6205963__fgene-09-00500-g001.html
  '@type': Dataset
  description: 'Fibroblast of Growth Factor (FGF) signaling activation and regulation.
    (A) Schematic of FGF subfamilies (see ). FGF10 belongs to the FGF7 subfamily and
    is highlighted in blue. (B) Comparison of FGF10 gene/protein in human and mouse.
    The human FGF10 gene has an extra exon; and the protein length in the two species
    differs by one amino acid. FGF10 is secreted via the canonical ER-Golgi secretory
    pathway, as demonstrated by the cleavage of the signal peptide, and have two known
    glycosylation sites (Source: UniProt). (C) Known disease-causing mutations on
    Fgf10 and Fgfr2 genes. The rare developmental disorders Aplasia of Lacrimal and
    major Salivary Glands (ALSG), Lacrimo-Auricuo-Dentro-Digital (LADD) syndrome,
    Aperts’ Syndrome and Bent Bone Dysplasia Syndrome (BBDS) result from either the
    loss of key receptor-binding sites on FGF10 or mutations in the receptor kinase
    (TK) domains or IgII linker regions (; , ; , ; ; ; ). Interestingly, cases of
    ALSG caused by the R193X mutation also coincide with Chronic Obstructive Pulmonary
    Disease (COPD) (). More recently, chromosomal translocation and duplication events
    at the loci of the Fgf10 and Fgfr2 genes have been associated with neurological
    disorders such as developmental delay and autism (; ). The role of single nucleotide
    polymorphisms and de novo point mutations causing oncogenic expression of Fgf10
    and Fgfr2 are also becoming clearer, particularly in pancreatic, gastric, and
    breast cancers (; ; ; ; ; ; ; ). (D) FGF10-dependent activation of FGFR intracellular
    tyrosine residues (Y; insert), adaptor proteins (gray), protein kinases (red),
    and transcription factors (blue). Insert on the right: each square represents
    a phosphorylated tyrosine residue (Y); the numbers correspond to phosphorylated
    Y residues on FGFR2b identified by proteomics; the color blue indicates higher
    phosphorylation at a given time point upon FGF10 stimulation of epithelial cells;
    modified from . Dashed arrows represent FGF10-specific activation or inhibition
    of signaling. The lightning bolt represents the activation of signaling cascades.
    (E) Left, FGF10 bound to heparan sulfate proteoglycans (HSPGs) in the ECM does
    not activate FGFR and intracellular signaling. Right, FGF10 bound to HSPGs and
    FGFR induces the recruitment of protein adaptors to FGFR and signaling activation
    (represented by lightning bolts). (F) Schematic representation of FGF10 regulation
    in response to hormones (orange), miRNAs (dark green), WNT and SHH proteins. (G)
    FGF10 induces FGFR2b internalization into early endosomes and sorting to recycling
    endosomes and plasma membrane. FGF10 has also been found in the nucleus of certain
    cell types.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF10
  - FGF3
  - FGF11
  - FGF8
  - FGF7
  - FGF12
  - FGF17
  - FGF21
  - FGF2
  - FGF13
  - FGF6
  - FGF18
  - FGF20
  - FGF23
  - FGF22
  - FGF14
  - FGFR2
  - COPD
  - ARCN1
  - FGFR1
  - FGFR3
  - FGFR4
  - FGFRL1
  - NAA50
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - GRB2
  - GAB2
  - FRS2
  - PTPN11
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XYLT2
  - SOS1
  - SOS2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - AKT1
  - AKT2
  - AKT3
  - SPRY1
  - SPRY2
  - SPRY3
  - SPRY4
  - KRAS
  - HRAS
  - NRAS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SH3BP4
  - ZFP36
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - SHH
  - HELT
  - HES1
  - GATD3
  - VAMP3
  - FGF1
  - FGF4
  - FGF5
  - FGF9
  - FGF16
  - FGF19
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - MIR17
  - MIR31
  - RTN4
  - SDC2
  - FGR
  - EFS
  - POLR3E
  - SMPD1
  - H19
  - PRS
  - S252F
  - Autism
  - cancer
  - Pancreatic Cancer
  - Breast cancer
  - ec000000000000000
  - X000000000000XX
---
